| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Kazuo Tsubota M.B.A., M.D., Ph.D. CEO | JPX Exchange | JP3535700003 ISIN |
| Japan Country | 17 Employees | - Last Dividend | - Last Split | - IPO Date |
Tsubota Laboratory Incorporated is a pioneering company based in Tokyo, Japan, that specializes in the research and development of pharmaceuticals and medical devices. Since its incorporation in 2012, the company has dedicated itself to addressing some of the most common ocular conditions, including myopia (nearsightedness), dry eyes, and presbyopia (age-related difficulty in seeing close objects). By harnessing cutting-edge science and technology, Tsubota Laboratory aims to improve the quality of life for individuals suffering from these conditions through innovative healthcare solutions.
Tsubota Laboratory develops advanced pharmaceuticals and medical devices aimed at correcting myopia. Leveraging the latest research in ocular health, the company creates solutions that not only aim to improve vision but also to address the underlying causes of myopia, promoting long-term eye health.
Understanding the discomfort and potential complications associated with dry eyes, Tsubota Laboratory offers a range of products designed to alleviate symptoms and restore moisture balance. These include specially formulated eye drops and devices that help maintain the natural moisture of the eyes, providing relief for sufferers of this common condition.
As part of its comprehensive approach to eye care, Tsubota Laboratory also innovates in the development of devices geared towards individuals experiencing presbyopia. The company's solutions focus on enhancing the ability to focus on close objects, thereby improving reading and detailed task performance for those affected by age-related vision changes.